{
 "drug": "Promethazine Hydrochloride Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "11/21/2023",
 "dayN": 1008,
 "cat": "Analgesia/Addiction",
 "companies": [
  "Hikma Pharmaceuticals USA, Inc.",
  "XGen Pharmaceuticals DJB, Inc."
 ],
 "reasons": [
  "Demand increase for the drug",
  "Other"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/21/2023",
   "package_ndc": "0641-6082-25",
   "generic_name": "Promethazine Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA083312"
    ],
    "brand_name": [
     "PHENERGAN"
    ],
    "generic_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6082",
     "0641-6083"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "992460",
     "992462",
     "992858",
     "992876"
    ],
    "spl_id": [
     "a64f0625-8d56-4994-8908-13614ca7b09f"
    ],
    "spl_set_id": [
     "6f7e47cc-f823-4336-8107-f980e3049617"
    ],
    "package_ndc": [
     "0641-6082-01",
     "0641-6082-25",
     "0641-6083-01",
     "0641-6083-25"
    ],
    "unii": [
     "R61ZEH7I1I"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Gastroenterology",
    "Pediatric",
    "Pulmonary/Allergy"
   ],
   "dosage_form": "Injection",
   "presentation": "Phenergan, Injection, 25 mg/1 mL (NDC 0641-6082-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/21/2023",
   "package_ndc": "0641-0929-25",
   "generic_name": "Promethazine Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA083312"
    ],
    "brand_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-0929",
     "0641-0928"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR"
    ],
    "substance_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "992460",
     "992858"
    ],
    "spl_id": [
     "9f14d3f5-ad01-44b5-a2b7-16ed5f501f87"
    ],
    "spl_set_id": [
     "4bf3912c-8339-401e-9711-dad6acf15f11"
    ],
    "package_ndc": [
     "0641-0928-21",
     "0641-0928-25",
     "0641-0929-21",
     "0641-0929-25"
    ],
    "unii": [
     "R61ZEH7I1I"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Gastroenterology",
    "Pediatric",
    "Pulmonary/Allergy"
   ],
   "dosage_form": "Injection",
   "presentation": "Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-0929-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/21/2023",
   "package_ndc": "0641-6083-25",
   "generic_name": "Promethazine Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "This presentation is temporarily on backorder.  Expected in October 2026 timeframe",
   "openfda": {
    "application_number": [
     "ANDA083312"
    ],
    "brand_name": [
     "PHENERGAN"
    ],
    "generic_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6083",
     "0641-6082"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR"
    ],
    "substance_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "992460",
     "992462",
     "992858",
     "992876"
    ],
    "spl_id": [
     "a64f0625-8d56-4994-8908-13614ca7b09f"
    ],
    "spl_set_id": [
     "6f7e47cc-f823-4336-8107-f980e3049617"
    ],
    "package_ndc": [
     "0641-6082-01",
     "0641-6082-25",
     "0641-6083-01",
     "0641-6083-25"
    ],
    "unii": [
     "R61ZEH7I1I"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Gastroenterology",
    "Pediatric",
    "Pulmonary/Allergy"
   ],
   "dosage_form": "Injection",
   "presentation": "Phenergan, Injection, 50 mg/1 mL (NDC 0641-6083-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/21/2023",
   "package_ndc": "0641-1496-35",
   "generic_name": "Promethazine Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA083312"
    ],
    "brand_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-1496",
     "0641-1495"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR"
    ],
    "substance_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "992460",
     "992858"
    ],
    "spl_id": [
     "80a400d2-d293-4180-bfa7-7a8ce0734bc5"
    ],
    "spl_set_id": [
     "13d9e59d-eadb-41d5-9f47-9c11a6efb31c"
    ],
    "package_ndc": [
     "0641-1495-31",
     "0641-1495-35",
     "0641-1496-31",
     "0641-1496-35"
    ],
    "unii": [
     "R61ZEH7I1I"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Gastroenterology",
    "Pediatric",
    "Pulmonary/Allergy"
   ],
   "dosage_form": "Injection",
   "presentation": "Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-1496-35)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/21/2023",
   "package_ndc": "0641-0928-25",
   "generic_name": "Promethazine Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA083312"
    ],
    "brand_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-0928",
     "0641-0929"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "992460",
     "992858"
    ],
    "spl_id": [
     "9f14d3f5-ad01-44b5-a2b7-16ed5f501f87"
    ],
    "spl_set_id": [
     "4bf3912c-8339-401e-9711-dad6acf15f11"
    ],
    "package_ndc": [
     "0641-0928-21",
     "0641-0928-25",
     "0641-0929-21",
     "0641-0929-25"
    ],
    "unii": [
     "R61ZEH7I1I"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Gastroenterology",
    "Pediatric",
    "Pulmonary/Allergy"
   ],
   "dosage_form": "Injection",
   "presentation": "Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/21/2023",
   "package_ndc": "0641-1495-35",
   "generic_name": "Promethazine Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA083312"
    ],
    "brand_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-1495",
     "0641-1496"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "992460",
     "992858"
    ],
    "spl_id": [
     "80a400d2-d293-4180-bfa7-7a8ce0734bc5"
    ],
    "spl_set_id": [
     "13d9e59d-eadb-41d5-9f47-9c11a6efb31c"
    ],
    "package_ndc": [
     "0641-1495-31",
     "0641-1495-35",
     "0641-1496-31",
     "0641-1496-35"
    ],
    "unii": [
     "R61ZEH7I1I"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Gastroenterology",
    "Pediatric",
    "Pulmonary/Allergy"
   ],
   "dosage_form": "Injection",
   "presentation": "Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/21/2023",
   "package_ndc": "39822-5550-6",
   "generic_name": "Promethazine Hydrochloride Injection",
   "contact_info": "866-390-4411",
   "availability": "Unvailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA040737"
    ],
    "brand_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "XGen Pharmaceuticals DJB, Inc."
    ],
    "product_ndc": [
     "39822-5550"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "992858"
    ],
    "spl_id": [
     "0e860109-725f-1c28-e063-6394a90a50ef"
    ],
    "spl_set_id": [
     "b6f6698f-f23c-452a-9b38-bbb96ab88ae4"
    ],
    "package_ndc": [
     "39822-5550-5",
     "39822-5550-6"
    ],
    "unii": [
     "R61ZEH7I1I"
    ]
   },
   "update_date": "06/23/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Gastroenterology",
    "Other",
    "Pulmonary/Allergy"
   ],
   "dosage_form": "Injection",
   "presentation": "Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6)",
   "company_name": "XGen Pharmaceuticals DJB, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/21/2023",
   "package_ndc": "39822-5525-3",
   "generic_name": "Promethazine Hydrochloride Injection",
   "contact_info": "866-390-4411",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA040737"
    ],
    "brand_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "XGen Pharmaceuticals DJB, Inc."
    ],
    "product_ndc": [
     "39822-5525"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "992460"
    ],
    "spl_id": [
     "0e3526e1-38be-1d89-e063-6294a90a775d"
    ],
    "spl_set_id": [
     "1d02d52b-84bb-4e81-b352-125029eb39f6"
    ],
    "package_ndc": [
     "39822-5525-2",
     "39822-5525-3"
    ],
    "unii": [
     "R61ZEH7I1I"
    ]
   },
   "update_date": "06/23/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Gastroenterology",
    "Other",
    "Pulmonary/Allergy"
   ],
   "dosage_form": "Injection",
   "presentation": "Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3)",
   "company_name": "XGen Pharmaceuticals DJB, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/21/2023",
   "package_ndc": "0641-6085-25",
   "generic_name": "Promethazine Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA083312"
    ],
    "brand_name": [
     "PHENERGAN"
    ],
    "generic_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6085",
     "0641-6084"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR"
    ],
    "substance_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "992460",
     "992462",
     "992858",
     "992876"
    ],
    "spl_id": [
     "7d6e64fc-bbf2-4ea9-b866-8115c448e687"
    ],
    "spl_set_id": [
     "481866da-a712-48a5-853f-8e84aacaab6d"
    ],
    "package_ndc": [
     "0641-6084-01",
     "0641-6084-25",
     "0641-6085-01",
     "0641-6085-25"
    ],
    "unii": [
     "R61ZEH7I1I"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Gastroenterology",
    "Pediatric",
    "Pulmonary/Allergy"
   ],
   "dosage_form": "Injection",
   "presentation": "Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/21/2023",
   "package_ndc": "0641-6084-25",
   "generic_name": "Promethazine Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA083312"
    ],
    "brand_name": [
     "PHENERGAN"
    ],
    "generic_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6084",
     "0641-6085"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "PROMETHAZINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "992460",
     "992462",
     "992858",
     "992876"
    ],
    "spl_id": [
     "7d6e64fc-bbf2-4ea9-b866-8115c448e687"
    ],
    "spl_set_id": [
     "481866da-a712-48a5-853f-8e84aacaab6d"
    ],
    "package_ndc": [
     "0641-6084-01",
     "0641-6084-25",
     "0641-6085-01",
     "0641-6085-25"
    ],
    "unii": [
     "R61ZEH7I1I"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Gastroenterology",
    "Pediatric",
    "Pulmonary/Allergy"
   ],
   "dosage_form": "Injection",
   "presentation": "Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  }
 ]
}